|
ИСТИНА |
Войти в систему Регистрация |
ИСТИНА ПсковГУ |
||
Clinical and morphological predictors of metastasis in papillary thyroid microcarcinomaстатья
Статья опубликована в высокорейтинговом журнале
Статья опубликована в журнале из списка Web of Science и/или Scopus- Авторы: Varlamov Andrey, Elfimova Alina, Matrosova Alina, Pachuashvili Nano, Dzodzaeva Ariya, Slashchuk Konstantin, Nikiforovich Petr, Beltsevich Dmitry, Vanushko Vladimir, Urusova Liliya
- Журнал: Frontiers in endocrinology
- Том: 16
- Год издания: 2025
- Издательство: Frontiers Research Foundation]
- Местоположение издательства: [Lausanne, Switzerland
- Номер статьи: 1637850
- DOI: 10.3389/fendo.2025.1637850
- Аннотация: Introduction: Papillary thyroid microcarcinomas (PTMCs), defined as papillary thyroid carcinomas measuring ≤1 cm, are frequently diagnosed incidentally and are generally associated with favorable outcomes. However, a significant subset of patients develops regional lymph node metastases. This study aimed to identify clinical and morphological features associated with metastatic spread in PTMCs. Methods: A total of 100 cases were retrospectively analyzed, including 50 with confirmed lymph node metastases and 50 without. A detailed histological assessment included evaluation of tumor subtype, nuclear features, presence of psammoma bodies, tumor “buds,” fibrosis, and other parameters. Clinical variables such as age, sex, body mass index, and presence of the BRAF V600E mutation were also considered. Results: Logistic regression revealed that younger age, classical histological subtype, tumor “budding,” and presence of psammoma bodies were independently associated with an increased risk of regional metastases, while concomitant multinodular hyperplasia was negatively associated. Discussion: The combination of these features may enhance risk stratification and guide the clinical management of PTMC patients, including decisions on surgical extent and follow-up strategies. Our findings support the relevance of comprehensive histological and clinical evaluation in predicting the metastatic potential of PTMCs.
- Добавил в систему: Урусова Лилия Сергеевна